COSCIENS Biopharma Inc. CSCIF
Set alert
6.10 USD -0.34 -5.28%
At close · Oct 30
6.43 Day range 6.44
0.79 52-week range 9.50
- YTD
- +196.12%
- 1 year
- +138.28%
- Open
- 6.43
- Prev close
- 6.44
- Mkt cap
- 6.08M
- Vol
- 1.00K
- Avg vol
- 354
- EPS
- -4.12
- P/E
- 0.00
More statistics
- Low
- 6.43
- High
- 6.44
2Y chart
Events in this range
- Jul 7, 2026Split: 1 for 150
Signals (69)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| RSI: Overbought | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 1 month ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| RSI: Overbought | Jul 7, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 4 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| SMA: Bearish | Apr 8, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| RSI: Overbought | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 2, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| RSI: Oversold | Feb 26, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 19, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 17, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 11, 2026 | 8 months ago |
| RSI: Oversold | Feb 11, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 10, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 22, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 2, 2025 | 11 months ago |
| RSI: Oversold | Nov 17, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 12, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 4, 2025 | 12 months ago |
| MACD: Buy Signal | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 3, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 28, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| RSI: Oversold | Aug 15, 2025 | 1 year ago |
| SMA: Bearish | Aug 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| RSI: Overbought | Jul 17, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jun 20, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 17, 2025 | 1 year ago |
| SMA: Bearish | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Apr 3, 2025 | 1 year ago |
| SMA: Bullish | Apr 2, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 27, 2025 | 1 year ago |
| RSI: Overbought | Mar 19, 2025 | 1 year ago |
| SMA: Bullish | Mar 13, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 13, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 28, 2025 | 1 year ago |
| SMA: Bullish | Feb 27, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 12, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 21, 2025 | 1 year ago |
| SMA: Bearish | Jan 15, 2025 | 1 year ago |
Financials — quick view
CSCIF Revenue — quarterly 2.75M
CSCIF Net income — quarterly -2.70M
CSCIF EPS — quarterly -0.85
News
- COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING
- COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING
- COSCIENS ACQUIRES NUALTIS CORP.
- COSCIENS Biopharma Inc. Reports Q2 2026 Results
- COSCIENS Biopharma Inc. Completes Share Capital Amendment
- COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment
- COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO
- COSCIENS Biopharma Inc. Reports Q1 2026 Results
- COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations
- COSCIENS Comments on Unusual Market Activity
Your note
Sign in to keep a note on CSCIF — it syncs with the Stock Master app.